Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 8-K (Current Report)
Reporting Period: First Quarter ended March 31, 1998
Date of Report: April 22, 1998
This filing reports first-quarter 1998 earnings, marking the sixteenth consecutive quarter of record earnings for comparable periods before nonrecurring charges. The company operates through six primary segments: Chemicals, Fibers, Polymers, Petroleum (Conoco), Life Sciences, and Diversified Businesses.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 | Change |
|---|---|---|---|
| Sales | $10,965 million | $11,211 million | -2% |
| Net Income (Reported) | $906 million | $1,020 million | -11% |
| Net Income (Excl. Nonrecurring) | $1,051 million | $1,020 million | +3% |
| Diluted EPS (Reported) | $0.79 | $0.89 | -11% |
| Diluted EPS (Excl. Nonrecurring) | $0.92 | $0.89 | +3% |
| Dividends Per Share | $0.315 | $0.285 | +10.5% |
Nonrecurring Charges: Total after-tax charges of $145 million ($0.13 per share) were recorded, consisting of $60 million for a revision of the purchase price allocation for Protein Technologies International and $85 million for the modernization of global nylon operations.
Material Changes vs. Prior Period
- Sales Decline: Consolidated sales decreased 2% primarily due to lower sales in the Petroleum segment (Conoco), which dropped 11% to $4.771 billion.
- Petroleum Segment: Earnings fell 13% to $287 million. Upstream earnings dropped 19% due to crude oil prices averaging $13.64 per barrel (34% lower than the prior year) and natural gas prices 18% lower. Downstream earnings rose 13% due to higher European refined product margins.
- Chemicals and Specialties: Combined earnings before nonrecurring charges rose 11%. Sales increased 8% on a continuing business basis, driven by 9% higher volumes. Average worldwide selling prices were up 3% excluding currency impacts.
- Segment Performance:
- Chemicals: Earnings up 24% to $177 million; sales up 2%.
- Fibers: Earnings essentially flat at $229 million (excluding nonrecurring charges); sales down 1% due to competitive pressure on polyester.
- Polymers: Earnings up 11% to $230 million; sales up 6%.
- Life Sciences: Earnings up 6% to $150 million (excluding nonrecurring charges); sales up 12%.
- Diversified Businesses: Earnings up 45% to $81 million; sales up 25%.
Guidance, Outlook, and Risks
Management Commentary: CEO Charles O. Holliday, Jr. attributed the record performance to employee efforts despite a stronger dollar, economic weakness in Asia, and lower oil prices. The company announced a restructuring program to focus on profitable growth.
Outlook: Management expects favorable raw material pricing and reduced currency impact in the second half of the year, projecting opportunities to deliver another record year.
Risks and Contingencies:
- Commodity Prices: Significant exposure to crude oil and natural gas price volatility, which severely impacted the Petroleum segment.
- Currency: A stronger dollar imposed an estimated 15% penalty on earnings.
- Competition: Intense competitive pressure from Asian imports affected the Fibers segment (specifically polyester).
- Restructuring: Ongoing modernization of nylon operations involves shutdowns and employee separation costs.
Investor Verification Checklist
- Verify the sustainability of the 11% earnings growth in Chemicals and Specialties given the 15% currency penalty.
- Assess the impact of the $85 million nylon modernization charge on future operating costs and capacity.
- Monitor crude oil and natural gas price trends to evaluate the recovery potential of the Petroleum segment.
- Review the integration progress of recent acquisitions contributing to volume growth in Chemicals and Life Sciences.
- Confirm the timeline and cost implications of the announced restructuring program.